ATC Group: D04AA02 Mepyramine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D04AA02 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D04 Antipruritics, incl. antihistamines, anesthetics, etc.
3 D04A Antipruritics, incl. antihistamines, anesthetics, etc.
4 D04AA Antihistamines for topical use
5 D04AA02 Mepyramine

Active ingredients in D04AA02

Active Ingredient Description
Mepyramine

Mepyramine is a first generation antihistamine, targeting the H1 receptor. However, it rapidly permeates the brain and so often causes drowsiness as a side effect. Mepyramine is a histamine H1 receptor inverse agonist. It binds to a G protein-coupled form of the receptor and promotes a G protein-coupled inactive state of the H1 receptor that interferes with the Gq/11-mediated signaling. Mepyramine competes with histamine for binding at H1-receptor sites on the effector cell surface, resulting in suppression of histaminic edema, flare, and pruritus. The sedative properties of mepyramine occur at the subcortical level of the CNS. It has mild hypnotic properties and some local anesthetic action and is used for allergies (including skin eruptions) both parenterally and locally. It is a common ingredient of cold remedies.

Related product monographs

Title Information Source Document Type  
ANTHISAN BITE AND STING Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

Ireland (IE)

Malta (MT)

New Zealand (NZ)

South Africa (ZA)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.